MammoVerse: Clinicians Focus Group

MammoVerse: Clinicians Exploring the Gaps for Treatment and Support for Women Breast Cancer Patients in Florida

Status

Enrolling by invitation

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT07644845

Enrollment

Registered

2026-06-12

Start date

2026-02-26

Completion date

2026-12-31

Last updated

2026-06-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Keywords

Oncology, Clinicians, focus group, support

Brief summary

The purpose of this study is to gather insights from clinicians who provide care to women diagnosed with breast cancer in Florida in order to identify gaps in emotional and mental health support encountered throughout the cancer care continuum. Clinicians will participate in virtual focus group discussions and complete a brief online demographic questionnaire. By capturing clinicians' perspectives on unmet psychosocial needs, barriers to support, and opportunities to improve patient-centered care, this study aims to inform the refinement of MammoVerse, an AI-based digital support platform intended to enhance emotional well-being, peer connection, and healthcare engagement among women facing breast cancer. This study offers preliminary data to inform the development of the MammoVerse AI platform later.

Interventions

None listed

Study design

Observational model

CASE_ONLY

Time perspective

CROSS_SECTIONAL

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Yes

Inclusion criteria

* they are an adult (over 18) * physician (MD or DO), licensed psychologist (PhD or PsyD), advanced practice provider (ARNP or PA), nurse (RN or LPN), licensed clinical social worker (LCSW) or other licensed clinician * provide specialized cancer care to women diagnosed with breast cancer in Florida * can provide informed consent * are self-reporting that they licensed clinicians * are self-reporting that they are physically able to participate in a 60-minute group discussion.

Exclusion criteria

* This study will NOT include persons under the age of 18, prisoners, and persons unable to speak English fluently, and persons unable to provide informed consent. We are not able to accommodate non-English speakers as this is a pilot study involving group discussion.

Design outcomes

Primary

Measure	Time frame	Description
Clinician Based Focus Group to assess Emotional and Psychosocial Experiences of Women Diagnosed with Breast Cancer	6 months	This focus group study serves as the qualitative foundation for understanding the emotional and psychosocial experiences of women diagnosed with breast cancer from their clinicians' viewpoints. Insights from this exploratory work will guide future quantitative validation and the design of digital psychosocial interventions, such as AI-driven conversational tools, to provide empathetic and contextually relevant emotional support

Countries

United States

Outcome results